Finasteride shown to prevent prostate cancer for up to 16 years

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Men who take the medication finasteride get a prostate cancer prevention benefit that can last 16 years—twice as long as previously recorded, according to SWOG clinical trial analysis published in the Journal of the National Cancer Institute.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login